Corvus Pharmaceuticals, Inc. has entered into an Amended and Restated Open Market Sale Agreement with Jefferies LLC to sell up to $200 million of its common stock. This agreement updates a previous $100 million agreement, allowing for increased capital raising potential.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.